Altamira Therapeutics .(CYTO) - 2022 Q4 - Annual Report
Altamira Therapeutics .(CYTO)2023-05-15 16:00HAMILTON, BERMUDA -- May 16, 2023 -- Altamira Therapeutics Ltd. (Nasdaq:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs, today provided a business update and reported its full year 2022 financial results ended December 31, 2022. Altamira Therapeutics Provides Business Update, Reports FY 2022 Financial Results "We continue to make good progress on our journey to become a leading provider of innovative RNA delivery technology," stated Thomas Meyer, Altamira Therapeut ...